This is a StreetInsider.com Premium Only Page

PAVmed (PAVM) – Analyst Ratings

Jan 20, 2023 06:37 AM Cantor Fitzgerald Downgrades PAVmed (PAVM) to Neutral

May 13, 2022 06:10 AM Cantor Fitzgerald Reiterates Overweight Rating, $5 on PAVmed (PAVM), "Encourage Investors to Acquire PAVM Shares at Attractive Valuation"

Mar 30, 2022 06:19 AM

Mar 29, 2021 04:38 PM

Nov 5, 2020 04:01 AM

Oct 13, 2020 08:45 AM

Jun 28, 2018 08:04 AM

Sep 5, 2017 08:25 AM